Treatment

Damoctocog alfa pegol (Jivi, BAY94-9027) clinical trials

2 indexed studies · 0 currently recruiting

Active not recruiting
Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding
This study looks at how safe a medicine called Jivi is for people with haemophilia A over a long time. It checks patients who are already using Jivi to prevent bleeding, gathering information during their regular doctor visits.
For: Hemophilia A
Austria · Germany · Greece
Active not recruiting
Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
This study looks at how a medicine called Jivi (damoctocog alfa pegol) works for people with haemophilia A in their daily lives. It checks its long-term safety and how happy patients and doctors are with it.
For: Hemophilia A
United States · Belgium · Brazil